OptimizeRx Corp (OPRX) is a leading provider of digital health solutions that connects pharmaceutical companies to healthcare providers, helping them to ensure better patient care and improved health outcomes. The company primarily operates via its cloud-based platform where it provides value-added services, offering healthcare professionals with the required resources to help their patients better manage treatment costs and medication adherence.
Founded in 2008 and headquartered in Rochester, Michigan, OptimizeRx Corp began with a vision to streamline the healthcare sector by digitizing the process of distributing drug samples within a healthcare setting. However, over the years, it has expanded its services, integrating directly into the electronic health records (EHR), making it easier for 600,000 healthcare providers to take advantage of its services.
OptimizeRx provides a range of solutions, including financial messaging, brand messaging, brand support, and patient engagement services. Financial messaging includes savings programs and co-pay programs designed to make medications more affordable for patients. Meanwhile, brand support services help providers become aware of new pharmaceutical brands and relevant updates. On the other hand, patient engagement services provide tools and resources designed to improve patient adherence to prescribed treatments.
At its core, OptimizeRx aims to remove cost barriers and improve medication adherence by delivering timely and relevant healthcare information to practitioners right within their EHR workflow. Because of its unique business model, the company has developed strong relationships with top EHR providers, positioning it well within the market to take advantage of future growth opportunities.
The company’s solutions have gained widespread acceptance, propelling OptimizeRx forward as a trusted partner for many pharmaceutical companies and healthcare providers alike. Its customer base includes over half of the top 20 pharmaceutical companies globally, underlying its leadership position in the market. OptimizeRx Corp is publicly traded on NASDAQ as OPRX.
Over the years, OptimizeRx has been lauded for its innovative and impactful services. In 2019, it was recognized as one of the fastest-growing companies by Deloitte's Technology Fast 500™. The company received the distinction due to its impressive revenue growth of 183% from 2015 to 2018.
Overall, OptimizeRx Corp continues to push the boundaries in digital health, helping to streamline communications between pharmaceutical companies and healthcare providers. The company's innovative platform, focused services, and drive to improve patient health outcomes positions it as one of the leaders within the sector.